Table 2.

Fever, improvement of QoL and HBV-DNA in trials included in the analysis

Event	No. of pts (%)		OR	95% CI	p value
	Non - CIK	CIK
Fever	0	12.40%	0.07	0.01 - 0.53	0.010
QOL improvement	58.54%	76.83%	0.32	0.16 - 0.64	0.001
QOL stability	31.70%	19.51%	2.52	1.22 - 5.20	0.010
QOL deterioration	9.76%	3.66%	2.91	0.79 - 10.64	0.110
HBV-DNA (> 1 × 103 copy/ml)	91.30%	27.59%	27.50	5.21 - 145.15	< 0.010

Summary differences of fever, improvement of QoL and HBV-DNA were calculated using the random-effects model.

Note: QoL quality of life; HBV-DNA Hepatitis B virus DNA; pts patients; CIK CIK-containing therapy; OR odds ratio; CI confidence interval.